News for KYOWA KIRIN CO. LTD. (KY4.DU)

/PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced the completion of a clinical study in Japan for a product using Terumo's automated injection...

TOKYO, Feb. 7, 2021 /CNW/ -- Terumo Corporation (TSE: 4543) today announced the completion of a clinical study in Japan for a product using Terumo...

TOKYO, Feb. 8, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced the completion of a clinical study in Japan for a product using...

TOKYO, Feb. 7, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced the completion of a clinical study in Japan for a product using...

Aiming to Reduce the Burden on Patients Receiving Ambulatory ChemotherapyTOKYO, Feb. 8, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today ...

Aiming to Reduce the Burden on Patients Receiving Ambulatory ChemotherapyTOKYO, Feb. 7, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today ...

TOKYO, Feb. 7, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced the completion of a clinical study in Japan for a product using Terumo's

Terumo Corporation (TSE: 4543) today announced the completion of a clinical study in Japan for a product using Terumo's automated injection device developed in collaboration with Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin).